The Veterans Spinal Trauma Access to New Devices (Veterans STAND) Act adds a new subsection to 38 U.S.C. §1706 directing the Secretary of Veterans Affairs to offer an annual preventative health evaluation to any veteran with a spinal cord injury or disorder who opts in. The statute specifies the subjects that evaluation must cover—risk of related complications, chronic pain, diet and weight management, prosthetic equipment function and safety, and assessment for assistive technologies including spinal cord neuromodulation.
Beyond clinical content, the bill forces several operational changes: the VA must consult clinical program managers, spinal cord specialists, neuromodulation experts, and veterans’ organizations when issuing related guidance; manufacturers must be consulted if guidance affects them; the Secretary must use telehealth where clinically appropriate for training and follow-up; and VA must report to congressional veterans committees on utilization, prescriptions, and functional outcomes on a set schedule. The measure also requires that Veterans Integrated Service Network (VISN) performance reviews incorporate provision of these evaluations.
At a Glance
What It Does
The bill adds subsection (d) to 38 U.S.C. §1706, requiring the VA to make an annual preventative health evaluation available to veterans with spinal cord injuries or disorders and to assess and expand access to assistive technologies. It authorizes use of direct care, referrals, or VA telehealth to deliver evaluations and follow-up, and mandates stakeholder consultation for guidance affecting device provision.
Who It Affects
Directly affects veterans with spinal cord injuries or disorders, VA spinal cord care teams and VISNs, manufacturers and suppliers of assistive devices (including neuromodulation firms), and telehealth service programs used by the VA. It also touches veterans’ service organizations that the Secretary must consult.
Why It Matters
This statute creates a formal pathway for identifying needs and prescribing assistive technologies—shifting spinal cord care from ad hoc device adoption toward a programmatic model with reporting, metrics, and explicit clinical consultation requirements. For providers and manufacturers it means clearer expectations and new administrative touchpoints with VA procurement and clinical guidance.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill inserts a new, mandatory offer into VA care: every veteran known to the VA with a spinal cord injury or disorder must be offered a preventative evaluation once per year, and the veteran may elect to receive it. The VA can deliver that evaluation directly, refer the veteran to another provider, or run it through a VA-operated telehealth program.
The statute does not create an entitlement to a device but requires standardized assessment for device need and suitability.
The statute lists specific assessment topics the VA must cover during the evaluation: identification of risks for spinal-cord-related complications and comorbidities; a structured look at chronic pain and its management; dietary and weight-management screening; review and safety-check of prosthetic equipment; and a dedicated evaluation of assistive-technology options. For assistive technologies the bill explicitly includes powered mobility aids (e.g., powered exoskeletons), speech-generating devices, and spinal cord neuromodulation approaches including non-invasive transcutaneous stimulation, and allows for FDA-approved implantable spinal cord stimulators where clinically appropriate.Operationally, the Secretary must consult a set list of advisors—VA spinal cord program managers, VA clinicians who specialize in SCI/D, outside clinicians and technologists with neuromodulation expertise, and recognized veterans’ organizations—when drafting guidance.
If proposed rules would affect manufacturers or device suppliers, the Secretary must consult those parties as well. The bill also directs the VA to try to ensure veterans known to have spinal cord injuries receive annual notice about the evaluation.Finally, the statute builds in measurement and congressional reporting.
The VA must submit a report to the congressional Veterans’ Affairs committees one year after enactment and then every two years that counts veterans who used, were assessed for, or were prescribed assistive technologies; identifies device categories and, where available, functional outcomes; and shows year-to-year change in evaluation uptake. The bill instructs the Secretary to include provision of these evaluations in VISN performance reviews beginning in the performance year that starts one year after enactment.
The Five Things You Need to Know
The VA must offer—but not compel—an annual preventative evaluation to any veteran with a spinal cord injury or disorder via direct care, referral, or VA telehealth.
The statutory evaluation must cover five domains: risk of spinal-cord-related complications, chronic pain, dietary and weight management, prosthetic equipment needs and safety, and assessment for assistive technologies including neuromodulation.
The Secretary must consult VA spinal cord program managers, VA specialist clinicians, outside neuromodulation experts, and recognized veterans’ organizations when issuing guidance, and must separately consult manufacturers if guidance would directly affect them.
Reporting to the House and Senate Veterans’ Affairs Committees is required one year after enactment and every two years thereafter and must include counts of veterans who used, were assessed for, and were prescribed assistive technologies, categories of devices, functional outcome summaries (if available), and year-to-year change in evaluation uptake.
The statute defines ‘assistive technology’ to include powered exoskeletons, speech-generating devices, non-invasive transcutaneous spinal stimulation intended to improve motor or autonomic function, and, where clinically appropriate and consistent with VA prosthetics policy, FDA-approved implantable spinal cord stimulation systems.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Gives the Act its public name: the Veterans Spinal Trauma Access to New Devices Act, or Veterans STAND Act. This is solely nominative—there are no substantive obligations attached to the short title itself.
Mandate to offer annual preventative evaluations
Adds a new subsection (d) requiring the VA to offer annually a preventative health evaluation to any veteran with a spinal cord injury or disorder who elects to undergo it. The VA may provide the evaluation through direct services, referral, or telehealth. Practically, this creates a recurring touchpoint to reassess needs rather than relying on episodic requests or referrals from unrelated encounters.
What must be assessed during the evaluation
Enumerates five assessment areas: risk of complications and comorbidities, chronic pain and its management, dietary and weight management, prosthetic equipment function and safety, and assistive technology suitability (including neuromodulation). For prosthetics and assistive devices the VA must consider current functioning, safety issues, and suitability for home use, including training and remote follow-up needs—factors that affect procurement and clinical-support planning.
Who the Secretary must consult before issuing guidance
Requires consultation with internal VA spinal cord program managers and specialist clinicians, outside clinicians and technologists experienced in neuromodulation, and veterans’ organizations recognized under 38 U.S.C. §5902. If guidance would directly affect manufacturers or suppliers, the VA must consult them as well. This builds a formal stakeholder loop into regulatory drafting and raises expectations for industry engagement prior to substantive policy changes.
Telehealth authority for training and monitoring
Allows the Secretary to provide training, device programming, remote monitoring, and follow-up for assistive technologies via telehealth when clinically appropriate. That authorization reduces geographic barriers and signals that the VA expects some devices to require remote services as part of the package of care, which has implications for staffing, telehealth bandwidth, and contracting for remote-device support.
Congressional reporting and VISN performance consideration
Mandates a report to congressional Veterans’ Affairs committees one year after enactment and every two years thereafter that tallies veterans who used, were assessed for, and were prescribed assistive technologies, identifies device categories and summarizes functional outcomes where available, and provides year-to-year change in evaluation uptake including the two prior years. Additionally, the statute instructs the Secretary to factor provision of these evaluations into VISN performance reviews for years beginning one year after enactment, linking program delivery to regional performance assessments.
This bill is one of many.
Codify tracks hundreds of bills on Veterans across all five countries.
Explore Veterans in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Veterans with spinal cord injuries or disorders — receive a standardized annual check that specifically screens for device needs, pain, nutrition, prosthetic safety, and novel assistive options, improving chances of timely access to devices and training.
- Caregivers and family members of affected veterans — benefit from explicit evaluation of home-use suitability and training options, which can reduce caregiver burden and safety risks associated with poorly matched devices.
- VA spinal cord injury programs and clinicians — gain a statutory mandate and clearer expectations for assessment scope and stakeholder consultation, which can justify program resources and interdisciplinary workflows.
- Manufacturers and device innovators in neuromodulation and mobility aids — receive formal consultation opportunities and a clearer VA pathway for device consideration, which may accelerate pilot programs or procurement conversations.
- Rural and otherwise access-challenged veterans — stand to gain more through authorized telehealth-based training, programming, and remote follow-up that the bill explicitly allows.
Who Bears the Cost
- Department of Veterans Affairs — must absorb operational costs for outreach, annual evaluations, telehealth delivery, clinician time, and infrastructure for training and remote monitoring unless Congress appropriates additional funds.
- Veterans Integrated Service Networks (VISNs) and facility administrators — will confront new performance expectations and must reallocate local resources to meet evaluation and reporting metrics.
- VA clinicians and rehabilitation staff — face added workload for conducting standardized annual evaluations, documenting device assessments, and providing or coordinating training and remote follow-up.
- Manufacturers and suppliers — while gaining consultative access, also face potential administrative burdens responding to VA consultations and potential procurement or post-market monitoring requirements tied to reported functional outcomes.
- Procurement and budgeting offices — could see increased short-term device acquisition costs and must handle decisions about investing in remotely supported devices and ongoing service contracts.
Key Issues
The Core Tension
The central dilemma is whether to accelerate access to emerging assistive technologies for veterans with spinal cord injuries—potentially improving mobility and quality of life—while simultaneously safeguarding patients and the VA budget by demanding sufficient clinical evidence, training, and sustainable funding; advancing one goal risks undermining the other.
The bill creates clear direction but leaves several operational questions unresolved. It mandates annual offers of evaluation and specific assessment topics, but it does not appropriate funds or specify how the VA should prioritize resources across competing care needs.
Implementation will require staffing, telehealth capacity, and prosthetics program expansion; without additional appropriations the VA will need to shift existing resources or reprioritize services, which could delay full implementation or create uneven access across VISNs.
The statute endorses specific assistive technologies—most notably various forms of spinal cord neuromodulation including non-invasive transcutaneous approaches—but ties coverage to clinical appropriateness and, for implants, FDA approval and existing prosthetics policies. That creates tension: rapid technological advances and limited high-quality long-term outcome data for some neuromodulation interventions will force VA clinicians and policy staff to define evidence thresholds for prescribing and for reporting functional outcomes.
The reporting mandate also raises practical questions about how the VA will measure and standardize ‘functional outcomes’ across diverse devices and patient populations, how it will attribute outcomes to specific technologies versus concurrent therapies, and how the VA will protect sensitive health data generated by remote monitoring and device programming.
Finally, the consultation requirements and the instruction to involve manufacturers when guidance affects them improve transparency but could slow rulemaking and blur the line between stakeholder engagement and industry capture. Facilities may vary in their ability to provide the telehealth-based programming and follow-up the bill contemplates, which risks creating a two-tiered system where veterans in better-resourced VISNs gain faster access to advanced devices and remote services than those in under-resourced regions.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.